Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1210/clinem/dgaa360 http://scihub22266oqcxt.onion/10.1210/clinem/dgaa360 32556147!7337869!32556147     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Endocrinol+Metab 2020 ; 105 (8): ä Nephropedia Template TP {{tp|p=32556147|t=2020. Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations |pdf=|usr=}}{{32556147}} gab.com Text Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations JO: J Clin Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=32556147 #FOAvip CONTEXT: While individuals with diabetes appear to be at similar risk for SARS-CoV-2 infection to those without diabetes, they are more likely to suffer severe consequences, including death. Diabetic ketoacidosis (DKA) is a common and potentially lethal acute complication of diabetes arising from a relative insulin deficiency, which occurs more often in those with type 1 diabetes and in the setting of moderate to severe illness. Early reports indicate that among patients with pre-existing diabetes, DKA may be a common complication of severe COVID-19 and a poor prognostic sign. CASE DESCRIPTION: This clinical perspective explores the key elements of caring for individuals with DKA during the COVID-19 pandemic through 2 cases. Topics addressed include diagnosis, triage, and the fundamental principles of treatment with a focus on the importance of characterizing DKA severity and medical complexity to determine the best approach. CONCLUSIONS: As discussed, some tenets of DKA management may require flexibility in the setting of COVID-19 due to important public health goals, such as preventing transmission to highest risk individuals, reducing healthcare worker exposure to infected patients, and preserving personal protective equipment. Evidence for alternative treatment strategies is explored, with special attention placed on treatment options that may be more relevant during the pandemic, including use of subcutaneous insulin therapy. Finally, DKA is often a preventable condition. We include evidence-based strategies and guidance designed to empower clinicians and patients to avoid this serious complication when possible. Twit Text FOAVip Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations ????J Clin Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=32556147 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32556147 #FOAvip English Wikipedia <ref>{{Cite pmid|32556147}}</ref> Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations #MMPMID32556147 Palermo NE; Sadhu AR; McDonnell ME J Clin Endocrinol Metab 2020[Aug]; 105 (8): ä PMID32556147show ga CONTEXT: While individuals with diabetes appear to be at similar risk for SARS-CoV-2 infection to those without diabetes, they are more likely to suffer severe consequences, including death. Diabetic ketoacidosis (DKA) is a common and potentially lethal acute complication of diabetes arising from a relative insulin deficiency, which occurs more often in those with type 1 diabetes and in the setting of moderate to severe illness. Early reports indicate that among patients with pre-existing diabetes, DKA may be a common complication of severe COVID-19 and a poor prognostic sign. CASE DESCRIPTION: This clinical perspective explores the key elements of caring for individuals with DKA during the COVID-19 pandemic through 2 cases. Topics addressed include diagnosis, triage, and the fundamental principles of treatment with a focus on the importance of characterizing DKA severity and medical complexity to determine the best approach. CONCLUSIONS: As discussed, some tenets of DKA management may require flexibility in the setting of COVID-19 due to important public health goals, such as preventing transmission to highest risk individuals, reducing healthcare worker exposure to infected patients, and preserving personal protective equipment. Evidence for alternative treatment strategies is explored, with special attention placed on treatment options that may be more relevant during the pandemic, including use of subcutaneous insulin therapy. Finally, DKA is often a preventable condition. We include evidence-based strategies and guidance designed to empower clinicians and patients to avoid this serious complication when possible. |*Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/mortality[MESH] |Diabetes Mellitus/mortality/*virology[MESH] |Diabetic Ketoacidosis/mortality/*virology[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/mortality[MESH] |Prognosis[MESH]Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations (epmc).pdf DeepDyve Pubget Overpricing